SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
RGEN

Repligen Corp (RGEN)

NASDAQ: RGEN · Real-Time Price · USD
Healthcare · Medical Instruments & Supplies
179.91+2.98 (+1.68%)
 
Market cap
$11.4B
Analyst consensus
Insider Score
––Not scored
RGEN Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

RGEN Stock Insider Trading Activity

RGEN stock’s insider trading shows 9 sales on the open market for an estimated $6.14M by company insiders over the last 6 months.

Not enough price history.

Insider Trading Activity (Form 4 Filings)

An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.

Scored window · last 90 days0 qualifying buys0 insiders$0 bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
InsiderActionSharesAvg CostTotalΔ HoldingsHeld AfterDateGradeForm 4
Douglass Brian Robb
Other
Award700—— 8.8%8,685Oct 6, 2026— Form 4
Loeillot Olivier
CEO
Sell4,202$190.00$798.38K 8.4%45,788Oct 5, 2026— Form 4
Loeillot Olivier
CEO
Option exercise4,202$154.96$651.14K 9.2%49,990Oct 5, 2026— Form 4
Loeillot Olivier
CEO
Sell1,333$178.75$238.27K 2.8%45,788Oct 5, 2026— Form 4
Loeillot Olivier
CEO
Tax withheld1,248$181.70$226.76K 2.6%47,121Oct 2, 2026— Form 4
Garland Jason K
CFO
Tax withheld421$189.68$79.86K 2.2%18,408Sep 25, 2026— Form 4
Loeillot Olivier
CEO
Sell4,542$190.00$862.98K 8.6%48,369Sep 24, 2026— Form 4
Loeillot Olivier
CEO
Option exercise8,404$154.96$1.30M 17.4%56,773Sep 24, 2026— Form 4
Loeillot Olivier
CEO
Sell8,404$190.00$1.60M 14.8%48,369Sep 24, 2026— Form 4
Loeillot Olivier
CEO
Option exercise4,542$155.38$705.74K 9.4%52,911Sep 24, 2026— Form 4
Loeillot Olivier
CEO
Option exercise5,426$141.79$769.35K 11.2%53,795Sep 21, 2026— Form 4
Loeillot Olivier
CEO
Sell5,426$180.00$976.68K 10.1%48,369Sep 21, 2026— Form 4
Loeillot Olivier
CEO
Sell3,035$165.90$503.51K 5.9%48,369Sep 4, 2026— Form 4
Loeillot Olivier
CEO
Tax withheld2,842$169.61$482.03K 5.2%51,404Sep 3, 2026— Form 4
Hughes Violetta
Other
Tax withheld277$170.02$47.10K 4.2%6,331Sep 1, 2026— Form 4
Loeillot Olivier
CEO
Option exercise5,426$141.79$769.35K 10.0%59,672Aug 20, 2026— Form 4
Loeillot Olivier
CEO
Sell5,426$180.00$976.68K 9.1%54,246Aug 20, 2026— Form 4
Garland Jason K
CFO
Sell530$150.00$79.50K 2.7%18,829Jul 16, 2026— Form 4
Garland Jason K
CFO
Sell733$145.00$106.28K 3.6%19,359Jun 25, 2026— Form 4
Mhatre Rohin
Director
Award995—— 24.8%5,014May 14, 2026— Form 4
Pax Margaret
Director
Award995—— 49.4%3,011May 14, 2026— Form 4
DAWES KAREN A
Director
Award995—— 1.1%92,816May 14, 2026— Form 4
BARTHELEMY NICOLAS
Director
Award995—— 22.4%5,436May 14, 2026— Form 4
EGLINTON MANNER CARRIE
Director
Award995—— 22.3%5,461May 14, 2026— Form 4
MUIR GLENN P
Director
Award995—— 2.5%40,051May 14, 2026— Form 4
Konstantinov Konstantin
Director
Award995—— 34.4%3,889May 14, 2026— Form 4
Madaus Martin D
Director
Award995—— 17.8%6,581May 14, 2026— Form 4
MUIR GLENN P
Director
Option exercise2,434$38.76$94.34K 6.6%39,056May 7, 2026— Form 4
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
  • Sell (S) — Open-market or private sale
  • Award (A) — Grant or award from the company, not a purchase
  • Tax withheld (F) — Shares withheld to pay tax or an exercise price
  • Option exercise (M) — Exercise or conversion of an exempt derivative
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.